Obesity and hypertension independently promote pathological left ventricular remodelling (LVR) and left ventricular hypertrophy (LVH), but to what extent they do so when they do not coexist is unclear. We used data from the Cardiovision Brno 2030 study to assess-for the first time in a region where no investigations have been previously carried out-the independent association of obesity and hypertension with LV geometry, and to evaluate the effects of hypertension in normal weight patients and the effects of obesity in normotensive patients. Overall, 433 individuals, aged 25⁻65 years, with no history of cardiovascular disease and/or antihypertensive treatment, were stratified into four groups according to BMI and hypertension: normal weight non-hypertensive (NWNH), normal weight hypertensive (NWH), overweight/obese non-hypertensive (ONH) and overweight/obese hypertensive (OH). LVR was classified as normal, concentric LVR (cLVR), concentric LVH (cLVH) or eccentric LVH (eLVH). Linear regression analysis demonstrated that body mass index (BMI) and systolic blood pressure (SBP) are the main predictors of LV mass and that they interact: SBP had a stronger effect in overweight/obese (β = 0.195; p = 0.033) compared to normal weight patients (β = 0.134; p = 0.048). Hypertension increased the odds of cLVR (OR = 1.78; 95%CI = 1.04⁻3.06; p = 0.037) and cLVH (OR = 8.20; 95% CI = 2.35⁻28.66; p = 0.001), independent of age, sex and BMI. Stratified analyses showed that NWH had a greater odd of cLVH (OR = 7.96; 95%CI = 1.70⁻37.08; p = 0.008) and cLVR (OR = 1.62; 95%CI = 1.02⁻3.34; p = 0.047) than NWNH. In the absence of hypertension, obesity was not associated with LVM and abnormal LV geometry, suggesting that it is not per se a determinant of LVR. Thus, antihypertensive therapy still remains the first-line approach against LVH in hypertensive patients, though weight loss interventions might be helpful in those who are obese.

Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation IRCCS ISMETT 90127 Palermo Italy

Department of Cardiovascular Medicine Division of Preventive Cardiology Mayo Clinic Rochester MN 55905 USA

Department of Medical and Surgical Sciences and Advanced Technologies GF Ingrassia University of Catania Via Santa Sofia 100 95123 Catania Italy

International Clinical Research Center St'Anne University Hospital 602 00 Brno Czech Republic

Zobrazit více v PubMed

Ganau A., Devereux R.B., Roman M.J., de Simone G., Pickering T.G., Saba P.S., Vargiu P., Simongini I., Laragh J.H. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J. Am. Coll. Cardiol. 1992;19:1550–1558. doi: 10.1016/0735-1097(92)90617-V. PubMed DOI

De Simone G., Daniels S.R., Kimball T.R., Roman M.J., Romano C., Chinali M., Galderisi M., Devereux R.B. Evaluation of concentric left ventricular geometry in humans: Evidence for age-related systematic underestimation. Hypertension. 2005;45:64–68. doi: 10.1161/01.HYP.0000150108.37527.57. PubMed DOI

Ortega F.B., Lavie C.J., Blair S.N. Obesity and Cardiovascular Disease. Circ. Res. 2016;118:1752–1770. doi: 10.1161/CIRCRESAHA.115.306883. PubMed DOI

Kjeldsen S.E. Hypertension and cardiovascular risk: General aspects. Pharmacol. Res. 2018;129:95–99. doi: 10.1016/j.phrs.2017.11.003. PubMed DOI

Zhang K., Huang F., Chen J., Cai Q., Wang T., Zou R., Zuo Z., Wang J., Huang H. Independent influence of overweight and obesity on the regression of left ventricular hypertrophy in hypertensive patients: A meta-analysis. Medicine. 2014;93:e130. doi: 10.1097/MD.0000000000000130. PubMed DOI PMC

De Cleva R., Araujo V.A., Buchalla C.C.O., de Oliveira Costa F., Cardoso A.F., Pajecki D., Santo M.A. Cardiac Remodeling Patterns in Severe Obesity According to Arterial Hypertension Grade. Obes. Surg. 2018;28:1047–1054. doi: 10.1007/s11695-017-2968-z. PubMed DOI

Aurigemma G.P., de Simone G., Fitzgibbons T.P. Cardiac remodeling in obesity. Circ. Cardiovasc. Imaging. 2013;6:142–152. doi: 10.1161/CIRCIMAGING.111.964627. PubMed DOI

Avelar E., Cloward T.V., Walker J.M., Farney R.J., Strong M., Pendleton R.C., Segerson N., Adams T.D., Gress R.E., Hunt S.C., et al. Left ventricular hypertrophy in severe obesity: Interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension. 2007;49:34–39. doi: 10.1161/01.HYP.0000251711.92482.14. PubMed DOI

Rodilla E., Costa J.A., Martin J., Gonzalez C., Pascual J.M., Redon J. Impact of abdominal obesity and ambulatory blood pressure in the diagnosis of left ventricular hypertrophy in never treated hypertensives. Med. Clin. 2014;142:235–242. doi: 10.1016/j.medcli.2013.04.046. PubMed DOI

Agodi A., Maugeri A., Kunzova S., Sochor O., Bauerova H., Kiacova N., Barchitta M., Vinciguerra M. Association of Dietary Patterns with Metabolic Syndrome: Results from the Kardiovize Brno 2030 Study. Nutrients. 2018;10:898. doi: 10.3390/nu10070898. PubMed DOI PMC

Maugeri A., Kunzova S., Medina-Inojosa J.R., Agodi A., Barchitta M., Homolka M., Kiacova N., Bauerova H., Sochor O., Lopez-Jimenez F., et al. Association between eating time interval and frequency with ideal cardiovascular health: Results from a random sample Czech urban population. Nutr. Metab. Cardiovasc. Dis. NMCD. 2018 doi: 10.1016/j.numecd.2018.04.002. PubMed DOI

Hruskova J., Maugeri A., Podrouzkova H., Stipalova T., Jakubik J., Barchitta M., Medina-Inojosa J.R., Homolka M., Agodi A., Kunzova S., et al. Association of Cardiovascular Health with Epicardial Adipose Tissue and Intima Media Thickness: The Kardiovize Study. J. Clin. Med. 2018;7:113. doi: 10.3390/jcm7050113. PubMed DOI PMC

Movsisyan N.K., Vinciguerra M., Lopez-Jimenez F., Kunzová Š., Homolka M., Jaresova J., Cífková R., Sochor O. Kardiovize Brno 2030, a prospective cardiovascular health study in Central Europe: Methods, baseline findings and future directions. Eur. J. Prev. Cardiol. 2017 doi: 10.1177/2047487317726623. PubMed DOI

Maugeri A., Medina-Inojosa J.R., Kunzova S., Agodi A., Barchitta M., Sochor O., Lopez-Jimenez F., Geda Y.E., Vinciguerra M. Sleep Duration and Excessive Daytime Sleepiness Are Associated with Obesity Independent of Diet and Physical Activity. Nutrients. 2018;10:1219. doi: 10.3390/nu10091219. PubMed DOI PMC

Maugeri A., Hruskova J., Jakubik J., Kunzova S., Sochor O., Barchitta M., Agodi A., Bauerova H., Medina-Inojosa J.R., Vinciguerra M. Dietary antioxidant intake decreases carotid intima media thickness in women but not in men: A cross-sectional assessment in the Kardiovize study. Free Radic. Biol. Med. 2019;131:274–281. doi: 10.1016/j.freeradbiomed.2018.12.018. PubMed DOI

World Health Organization Physical status: The use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ. Tech. Rep. Ser. 1995;854:1–452. PubMed

WHO . Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation. World Health Organization; Geneva, Switzerland: 2008.

Lang R.M., Badano L.P., Mor-Avi V., Afilalo J., Armstrong A., Ernande L., Flachskampf F.A., Foster E., Goldstein S.A., Kuznetsova T., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr. 2015;28:1–39.e14. doi: 10.1016/j.echo.2014.10.003. PubMed DOI

Zoghbi W.A., Adams D., Bonow R.O., Enriquez-Sarano M., Foster E., Grayburn P.A., Hahn R.T., Han Y., Hung J., Lang R.M., et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr. 2017;30:303–371. doi: 10.1016/j.echo.2017.01.007. PubMed DOI

Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F., 3rd., Dokainish H., Edvardsen T., Flachskampf F.A., Gillebert T.C., Klein A.L., Lancellotti P., et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr. 2016;29:277–314. doi: 10.1016/j.echo.2016.01.011. PubMed DOI

Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., Pratt M., Ekelund U., Yngve A., Sallis J.F., et al. International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports Exerc. 2003;35:1381–1395. doi: 10.1249/01.MSS.0000078924.61453.FB. PubMed DOI

Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jones D.W., Materson B.J., Oparil S., Wright J.T., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252. doi: 10.1161/01.HYP.0000107251.49515.c2. PubMed DOI

De Simone G., Izzo R., De Luca N., Gerdts E. Left ventricular geometry in obesity: Is it what we expect? Nutr. Metab. Cardiovasc. Dis. 2013;23:905–912. doi: 10.1016/j.numecd.2013.06.012. PubMed DOI

De Simone G., Palmieri V., Bella J.N., Celentano A., Hong Y., Oberman A., Kitzman D.W., Hopkins P.N., Arnett D.K., Devereux R.B. Association of left ventricular hypertrophy with metabolic risk factors: The HyperGEN study. J. Hypertens. 2002;20:323–331. doi: 10.1097/00004872-200202000-00024. PubMed DOI

Lauer M.S., Anderson K.M., Kannel W.B., Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA. 1991;266:231–236. doi: 10.1001/jama.1991.03470020057032. PubMed DOI

De Simone G., Devereux R.B., Roman M.J., Alderman M.H., Laragh J.H. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994;23:600–606. doi: 10.1161/01.HYP.23.5.600. PubMed DOI

Cuspidi C., Rescaldani M., Sala C., Grassi G. Left-ventricular hypertrophy and obesity: A systematic review and meta-analysis of echocardiographic studies. J. Hypertens. 2014;32:16–25. doi: 10.1097/HJH.0b013e328364fb58. PubMed DOI

Grossman W., Jones D., McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Investig. 1975;56:56–64. doi: 10.1172/JCI108079. PubMed DOI PMC

Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., Eckel R.H., American Heart Association. Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898–918. doi: 10.1161/CIRCULATIONAHA.106.171016. PubMed DOI

Cheng S., Fernandes V.R., Bluemke D.A., McClelland R.L., Kronmal R.A., Lima J.A. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: The Multi-Ethnic Study of Atherosclerosis. Circ. Cardiovasc. Imaging. 2009;2:191–198. doi: 10.1161/CIRCIMAGING.108.819938. PubMed DOI PMC

Heesen W.F., Beltman F.W., May J.F., Smit A.J., de Graeff P.A., Havinga T.K., Schuurman F.H., van der Veur E., Hamer J.P., Meyboom-de Jong B., et al. High prevalence of concentric remodeling in elderly individuals with isolated systolic hypertension from a population survey. Hypertension. 1997;29:539–543. doi: 10.1161/01.HYP.29.2.539. PubMed DOI

Kostkiewicz M., Tracz W., Olszowska M., Podolec P., Drop D. Left ventricular geometry and function in patients with aortic stenosis: Gender differences. Int. J. Cardiol. 1999;71:57–61. doi: 10.1016/S0167-5273(99)00114-X. PubMed DOI

Krumholz H.M., Larson M., Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am. J. Cardiol. 1993;72:310–313. doi: 10.1016/0002-9149(93)90678-6. PubMed DOI

Woodiwiss A.J., Norton G.R. Obesity and left ventricular hypertrophy: The hypertension connection. Curr. Hypertens. Rep. 2015;17:539. doi: 10.1007/s11906-015-0539-z. PubMed DOI

De Simone G., Kizer J.R., Chinali M., Roman M.J., Bella J.N., Best L.G., Lee E.T., Devereux R.B., Investigators S.H.S. Normalization for body size and population-attributable risk of left ventricular hypertrophy: The Strong Heart Study. Am. J. Hypertens. 2005;18:191–196. doi: 10.1016/j.amjhyper.2004.08.032. PubMed DOI

Alessandro Gondoni L., Titon A.M., Montano M., Nibbio F., Bertone G. The importance of a shared definition of left ventricular hypertrophy: The case of obese women. Int. J. Cardiol. 2017;227:404–406. doi: 10.1016/j.ijcard.2016.11.032. PubMed DOI

Schmieder R.E., Martus P., Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 1996;275:1507–1513. doi: 10.1001/jama.1996.03530430051039. PubMed DOI

Schmieder R.E., Schlaich M.P., Klingbeil A.U., Martus P. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996) Nephrol. Dial. Transpl. 1998;13:564–569. doi: 10.1093/ndt/13.3.564. PubMed DOI

Obesity-induced nucleosome release predicts poor cardio-metabolic health

How dietary patterns affect left ventricular structure, function and remodelling: evidence from the Kardiovize Brno 2030 study

Dog Ownership and Cardiovascular Health: Results From the Kardiovize 2030 Project